Announcement under Regulation 30 (LODR)-Resignation of Director
Filed with BSE · · 3 pages · English
The relevant details as required under Regulation 30 read with Schedule III of the SEBI Listing Regulations read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November 2024, are given in Annexure I. The resignation letter received from Mr. Pradeep Dnyaneshwar Terse is also enclosed. The Board of Directors of the Company has noted the same and placed on record its sincere app
Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And PharmaceuticalsLimited Held Today I.E. Monday, December 01, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 27 2025
- Board Meeting Intimation for Postponement Of Board Meeting Which Was To Be Held On Thursday, 27Th November, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Nov 24 2025
- Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, November 27, 2025
Later from Welcure Drugs and Pharmaceuticals
- Board Meeting Intimation for Intimation Of Rights Issue Committee Meeting To Be Held On 05Th December, 2025 ForDeciding Issue Price And Other Terms Of The Rights Issue
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 01 2025
- Postponement Of The Meeting Of The Rights Issue Committee Of Welcure Drugs And Pharmaceuticals Limited Which Was To Be Held Today I.E. Monday, December 05, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release Dec 05 2025
- Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Welcure Drugs And PharmaceuticalsLimited Held Today I.E. Saturday, December 06, 2025
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals